Crinetics Pharmaceuticals Inc. clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 4 with minor changes only.

1. Minor

   CAREFNDR · Carcinoid Syndrome Efficacy Study Featuring an Oral…CAREFNDR · Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

   Enrollment closed, study ongoing

   Crinetics Pharmaceuticals Inc.·Phase 3· NCT07087054· Registry history of NCT07087054 on ClinicalTrials.gov (opens the registry)

   Updated Oct 15, 2026

2. Minor

   CRN04894 · Cushing's Syndrome

   Trial completed

   Also in this update: Primary completion date changed from estimate of Oct 2026 to Aug 25, 2026

   Crinetics Pharmaceuticals Inc.·Phase 1/2· NCT05804669· Registry history of NCT05804669 on ClinicalTrials.gov (opens the registry)

   Updated Oct 14, 2026

3. Minor

   BRAVESST2 · CRN09682 · SST2-Expressing NENs and Other Solid…BRAVESST2 · CRN09682 · SST2-Expressing NENs and Other Solid Tumors

   Enrollment closed, study ongoing

   Crinetics Pharmaceuticals Inc.·Phase 1/2· NCT07129252· Registry history of NCT07129252 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

4. Minor

   Atumelnant · Congenital Adrenal Hyperplasia

   Trial sites expanded: 68 → 72 locations

   Crinetics Pharmaceuticals Inc.·Phase 3· NCT07144163· Registry history of NCT07144163 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.